Extended release formulations of erythromycin derivatives

Details Extended release formulations of erythromycin derivatives Extended release formulations of erythromycin derivatives

A - Human Necessities

61

K

A61K 31/7048 (2006.01) A61K 9/22 (2006.01) A61K 31/7042 (2006.01) A61P 31/04 (2006.01)

Patent

CA 2358395

An extended release pharmaceutical composition comprises an erythromycin derivative and a pharmaceutically acceptable polymer, the composition has an improved taste profile as compared to an immediate release composition of the erythromycin derivative.

Affiliated with

Also associated with

Rating

Extended release formulations of erythromycin derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Extended release formulations of erythromycin derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Extended release formulations of erythromycin derivatives will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1960225